Inhibrx, Inc.: insider trades · United States · SEC (Form 4)

Discover the full directors' dealings record of Inhibrx, Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Inhibrx, Inc. has published 1 public disclosures. Market capitalisation: €1.5bn. The latest transaction was reported on 7 April 2022 — Cession. Among the most active insiders: Eckelman Brendan P.. Every trade is accessible without an account.